Pantherics

company

About

Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$255.84K
Industries
Biotechnology,Life Science
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$480.59K
Pantherics has raised a total of $480.59K in funding over 2 rounds. Their latest funding was raised on Aug 11, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 11, 2022 Grant $255.84K 1 National Institutes of Health Detail
May 7, 2019 Grant $224.75K 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Pantherics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant